topic: Access to Medicines
MSF welcomes Indian Patent Office’s rejection of J&J’s application for paediatric formulation of lifesaving TB drug
MSF and Health Justice Initiative welcome J&J’s withdrawal of patents on lifesaving TB drug in South Africa
Secrets Cost Lives: Transparency and access to medical products
Danaher continues to charge exorbitant prices for lifesaving medical tests despite urgent demands for price reductions by several Ministries of Health
India: Mumbai TB Symposium Focuses on Advancing TB Treatment and Collaboration
India: How Deepak Shegar overcame DR-TB to reclaim his dreams
Deepak Shegar: Battling DR-TB with resilience and dreams
MSF responds to the outcomes of PPR negotiations at WHA77
Gavi’s next strategy must make sure to reach the 10 million children in fragile and humanitarian settings who are missing vaccines
